Furthermore, among the 649 AML patients included in this study, different clinical characteristics such as different platelet and leukocyte counts, basic diseases, complications, and tumor load level may affect the level of VEGF, which may be the source of heterogeneity. Here, VEGFA is linked to neoplasm.